A Clinical Trial of MK-8527 and Rifampin in Adult Participants With Latent Tuberculosis Infection (MK-8527-019)

Clinical trial NCT07600775 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07600775
Sponsor: Merck Sharp & Dohme LLC
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Human Immunodeficiency Virus (HIV)HIV Pre-Exposure Prophylaxis

Start date: 2026-09-01
Primary completion: 2027-01-19
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.